120 related articles for article (PubMed ID: 38159264)
1. Amelioration of Acute Radiation Dermatitis in Breast Cancer Patients by a Bioadhesive Barrier-Forming Gel (Episil): A Single-Center, Open, Parallel, Randomized, Phase I/II Controlled Trial.
Li Q; Feng S; Yu Z; Wang Y; Tian L; Geng H; Guo C; Ning F; Luo J; Liu C
Clin Pharmacol Ther; 2024 May; 115(5):1085-1091. PubMed ID: 38159264
[TBL] [Abstract][Full Text] [Related]
2. A Bioadhesive Barrier-Forming Oral Liquid Gel Improved Oral Mucositis and Nutritional Status in Patients With Head and Neck Cancers Undergoing Radiotherapy: A Retrospective Single Center Study.
Wei J; Wu J; Wang H; Wang B; Zhao T; Meng L; Dong L; Jiang X
Front Oncol; 2021; 11():617392. PubMed ID: 33692954
[TBL] [Abstract][Full Text] [Related]
3. Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
Ueno T; Yatsuoka W; Ishiki H; Miyano K; Uezono Y
BMC Cancer; 2022 Jan; 22(1):90. PubMed ID: 35062896
[TBL] [Abstract][Full Text] [Related]
4. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
[TBL] [Abstract][Full Text] [Related]
5. A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial.
Robijns J; Van Bever L; Hermans S; Claes M; Lodewijckx J; Lenaerts M; Tuts L; Vandaele E; Vinken E; Noé L; Verboven K; Maes A; Van de Velde AS; Bulens P; Bulens P; Van den Bergh L; Mebis J
Support Care Cancer; 2023 Oct; 31(12):625. PubMed ID: 37819539
[TBL] [Abstract][Full Text] [Related]
6. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
7. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
8. Randomized Pilot Study of a Keratin-based Topical Cream for Radiation Dermatitis in Breast Cancer Patients.
Winkfield KM; Hughes RT; Brown DR; Clohessy RM; Holder RC; Russell GB; Rejeski AF; Burnett LR
Technol Cancer Res Treat; 2024; 23():15330338231222137. PubMed ID: 38186361
[No Abstract] [Full Text] [Related]
9. Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer.
Ito K; Tokura S; Takazawa I; Yoshida N; Nakanishi T; Akiyama K; Onuma Y; Adachi T; Harada H; Nojima H; Miura M; Yoshimura R; Kabasawa Y
Heliyon; 2023 Jun; 9(6):e15869. PubMed ID: 37260888
[TBL] [Abstract][Full Text] [Related]
10. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
11. Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial).
Robijns J; Lodewijckx J; Puts S; Vanmechelen S; Van Bever L; Claes S; Pannekoeke L; Timmermans A; Noé L; Govers M; Van de Werf E; Maes A; Bulens P; Mebis J
Lasers Surg Med; 2022 Mar; 54(3):374-383. PubMed ID: 34481420
[TBL] [Abstract][Full Text] [Related]
12. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
14. No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions--results from a randomised blinded trial.
Sharp L; Finnilä K; Johansson H; Abrahamsson M; Hatschek T; Bergenmar M
Eur J Oncol Nurs; 2013 Aug; 17(4):429-35. PubMed ID: 23245940
[TBL] [Abstract][Full Text] [Related]
15. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Episil® in patients with hematologic malignancies: a comparative study.
Fukutani T; Yoshioka Y; Imori S; Yanagihara H; Sumi K; Myoken Y; Fujita Y; Yanamoto S
BMC Oral Health; 2024 May; 24(1):522. PubMed ID: 38698387
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness, safety, and economic evaluation of topical application of a herbal ointment, Jaungo, for radiation dermatitis after breast conserving surgery in patients with breast cancer (GREEN study): Study protocol for a randomized controlled trial.
Shin S; Jang BH; Suh HS; Park SH; Lee JW; Yoon SW; Kong M; Lim YJ; Hwang DS
Medicine (Baltimore); 2019 Apr; 98(15):e15174. PubMed ID: 30985703
[TBL] [Abstract][Full Text] [Related]
18. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
19. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
20. Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.
Talakesh T; Tabatabaee N; Atoof F; Aliasgharzadeh A; Sarvizade M; Farhood B; Najafi M
Curr Radiopharm; 2022; 15(4):332-340. PubMed ID: 35747962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
